China’s Bio-Thera begins trials to develop biosimilar to Actemra 01-Aug-2018 By Maggie Lynch A Phase I clinical trial to examine the safety and pharmacokinetics of BAT1806, an Actemra biosimilar, is to be conducted by Chinese pharmaceutical company Bio-Thera.